News
-
-
PRESS RELEASE
LR Health & Beauty SE publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm
LR Health & Beauty SE publishes bond prospectus and applies for trading of bonds on Nasdaq Stockholm's corporate bond list; LR Group's holistic business model and commitment to sustainability showcased -
-
-
-
PRESS RELEASE
EQS-Adhoc: LR Health & Beauty SE: Publication of figures for the third quarter of 2024 and adjustment of the forecast for the 2024 financial year
LR Health & Beauty SE reports increase in sales for Q3 2024, adjusts forecast for full year. Sales guidance raised to EUR 288-292 million, EBITDA forecast revised to EUR 26-29 million -
-
PRESS RELEASE
LR Health & Beauty SE bestätigt Wachstumstrend im zweiten Quartal 2024
LR Health & Beauty SE reports 2.6% sales growth, EUR 143.3 million in revenue, and new product launches in H1 2024, despite challenges. EBITDA at EUR 14.4 million. Future plans include IT expansion and product segment launch -
-
